EDGEWELL PERSONAL CARE Co
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
EPC$29.61+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(unaudited, in millions)
| Nine Months EndedJune 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash Flow from Operating Activities | ||
| Net (loss) earnings | $(62.6) | $56.0 |
| Depreciation and amortization | 59.0 | 65.6 |
| Share-based compensation expense | 14.7 | 18.8 |
| Loss on sale of assets | 1.4 | 1.7 |
| Impairment charges | 37.4 | — |
| Loss on assets held for sale | 2.2 | — |
| Deferred compensation payments | (2.3) | (2.4) |
| Deferred income taxes | (39.8) | (0.5) |
| Other, net | 8.3 | (12.2) |
| Changes in operating assets and liabilities | 28.8 | (82.7) |
| Net cash provided by operating activities | 47.1 | 44.3 |
| Cash Flow from Investing Activities | ||
| Proceeds from sale of business | 338.9 | — |
| Capital expenditures | (41.2) | (49.4) |
| Collection of deferred purchase price on accounts receivable sold | 3.3 | 5.6 |
| Other, net | — | (1.5) |
| Net cash provided by (used in) investing activities | 301.0 | (45.3) |
| Cash Flow from Financing Activities | ||
| Cash proceeds from debt with original maturities greater than 90 days | 398.0 | 774.0 |
| Cash payments on debt with original maturities greater than 90 days | (538.0) | (678.0) |
| Net proceeds from (payment of) debt with original maturities of 90 days or less | 3.1 | (0.8) |
| Repurchase of shares | (15.8) | (90.2) |
| Dividends to common shareholders | (21.5) | (22.4) |
| Employee shares withheld for taxes | (2.9) | (7.4) |
| Net financing inflow from the Accounts Receivable Facility | 2.7 | 14.2 |
| Other, net | (0.3) | (0.3) |
| Net cash used in financing activities | (174.7) | (10.9) |
| Effect of exchange rate changes on cash | (2.0) | 2.4 |
| Net increase (decrease) in cash and cash equivalents | 171.4 | (9.5) |
| Cash and cash equivalents, beginning of period | 225.7 | 209.1 |
| Cash and cash equivalents, end of period | $397.1 | $199.6 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.